560 related articles for article (PubMed ID: 34731465)
21. Application of machine intelligence technology in the detection of vaccines and medicines for SARS-CoV-2.
Alsharif MH; Alsharif YH; Albreem MA; Jahid A; Solyman AAA; Yahya K; Alomari OA; Hossain MS
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11977-11981. PubMed ID: 33275275
[TBL] [Abstract][Full Text] [Related]
22. A transferable deep learning approach to fast screen potential antiviral drugs against SARS-CoV-2.
Wang S; Sun Q; Xu Y; Pei J; Lai L
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34081143
[TBL] [Abstract][Full Text] [Related]
23. Drug Discovery by Drug Repurposing: Combating COVID-19 in the 21st Century.
Sanghai N; Shafiq K; Tranmer GK
Mini Rev Med Chem; 2021; 21(1):3-9. PubMed ID: 32838716
[TBL] [Abstract][Full Text] [Related]
24. Repurposing anticancer drugs for the management of COVID-19.
El Bairi K; Trapani D; Petrillo A; Le Page C; Zbakh H; Daniele B; Belbaraka R; Curigliano G; Afqir S
Eur J Cancer; 2020 Dec; 141():40-61. PubMed ID: 33125946
[TBL] [Abstract][Full Text] [Related]
25. SARS-CoV-2 multifaceted interaction with human host. Part I: What we have learnt and done so far, and the still unknown realities.
Delcuve GP; Lakowski TM; Su RC; Beacon TH; Davie JR
IUBMB Life; 2020 Nov; 72(11):2313-2330. PubMed ID: 32918855
[TBL] [Abstract][Full Text] [Related]
26. Emerging role of artificial intelligence in therapeutics for COVID-19: a systematic review.
Kaushal K; Sarma P; Rana SV; Medhi B; Naithani M
J Biomol Struct Dyn; 2022 Jul; 40(10):4750-4765. PubMed ID: 33300456
[TBL] [Abstract][Full Text] [Related]
27. Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study.
Baby K; Maity S; Mehta CH; Suresh A; Nayak UY; Nayak Y
Arch Med Res; 2021 Jan; 52(1):38-47. PubMed ID: 32962867
[TBL] [Abstract][Full Text] [Related]
28. Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19.
Majumder J; Minko T
AAPS J; 2021 Jan; 23(1):14. PubMed ID: 33400058
[TBL] [Abstract][Full Text] [Related]
29. A critical overview of computational approaches employed for COVID-19 drug discovery.
Muratov EN; Amaro R; Andrade CH; Brown N; Ekins S; Fourches D; Isayev O; Kozakov D; Medina-Franco JL; Merz KM; Oprea TI; Poroikov V; Schneider G; Todd MH; Varnek A; Winkler DA; Zakharov AV; Cherkasov A; Tropsha A
Chem Soc Rev; 2021 Aug; 50(16):9121-9151. PubMed ID: 34212944
[TBL] [Abstract][Full Text] [Related]
30. A review of COVID-19 biomarkers and drug targets: resources and tools.
Caruso FP; Scala G; Cerulo L; Ceccarelli M
Brief Bioinform; 2021 Mar; 22(2):701-713. PubMed ID: 33279954
[TBL] [Abstract][Full Text] [Related]
31. Therapeutics for COVID-19: from computation to practices-where we are, where we are heading to.
Ojha PK; Kar S; Krishna JG; Roy K; Leszczynski J
Mol Divers; 2021 Feb; 25(1):625-659. PubMed ID: 32880078
[TBL] [Abstract][Full Text] [Related]
32. A call to arms.
Service RF
Science; 2021 Mar; 371(6534):1092-1095. PubMed ID: 33707248
[No Abstract] [Full Text] [Related]
33. COVID-19 challenges and its therapeutics.
Rehman SU; Rehman SU; Yoo HH
Biomed Pharmacother; 2021 Oct; 142():112015. PubMed ID: 34388532
[TBL] [Abstract][Full Text] [Related]
34. Systematic Down-Selection of Repurposed Drug Candidates for COVID-19.
MacRaild CA; Mohammed MU; Faheem ; Murugesan S; Styles IK; Peterson AL; Kirkpatrick CMJ; Cooper MA; Palombo EA; Simpson MM; Jain HA; Agarwal V; McAuley AJ; Kumar A; Creek DJ; Trevaskis NL; Vasan SS
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233149
[TBL] [Abstract][Full Text] [Related]
35. COVID-19: Vaccine Delivery System, Drug Repurposing and Application of Molecular Modeling Approach.
Abd El Hadi SR; Zien El-Deen EE; Bahaa MM; Sadakah AA; Yassin HA
Drug Des Devel Ther; 2021; 15():3313-3330. PubMed ID: 34366663
[TBL] [Abstract][Full Text] [Related]
36. COVID-19: Advances in diagnostic tools, treatment strategies, and vaccine development.
Sreepadmanabh M; Sahu AK; Chande A
J Biosci; 2020; 45(1):. PubMed ID: 33410425
[TBL] [Abstract][Full Text] [Related]
37. Progress and pitfalls of a year of drug repurposing screens against COVID-19.
Sourimant J; Aggarwal M; Plemper RK
Curr Opin Virol; 2021 Aug; 49():183-193. PubMed ID: 34218010
[TBL] [Abstract][Full Text] [Related]
38. Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement.
Coban MA; Morrison J; Maharjan S; Hernandez Medina DH; Li W; Zhang YS; Freeman WD; Radisky ES; Le Roch KG; Weisend CM; Ebihara H; Caulfield TR
Biomolecules; 2021 May; 11(6):. PubMed ID: 34071060
[TBL] [Abstract][Full Text] [Related]
39. Repositioning of Drugs to Counter COVID-19 Pandemic - An Insight.
Akilesh SM; J R; Palanisamy D; Wadhwani A
Curr Pharm Biotechnol; 2021; 22(2):192-199. PubMed ID: 32867651
[TBL] [Abstract][Full Text] [Related]
40. Network-Driven Drug Discovery.
Wray J; Whitmore A
Methods Mol Biol; 2022; 2390():177-190. PubMed ID: 34731469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
